Nidra
Restless Legs Syndrome (RLS)
CommercialActive
Key Facts
About Noctrix Health
Noctrix Health is a private, commercial-stage medical device company based in San Jose, California, founded in 2018. The company has successfully developed and launched Nidra, an FDA-authorized wearable neuromodulation device for treating Restless Legs Syndrome (RLS), supported by pivotal clinical trial data published in a peer-reviewed journal. With recent CMS reimbursement codes, a $33.5M financing round, and inclusion in AASM clinical guidelines, Noctrix is positioned for U.S. commercialization growth while potentially expanding its technology platform to other chronic neurological disorders.
View full company profile